Back to products
RETATRUTIDE 20MG research information sheet
Research Use Only
Triple Agonist (GLP-1, GIP & Glucagon)

RETATRUTIDE 20MG

£75

Retatrutide is a triple agonist targeting the GLP-1, GIP and glucagon receptors simultaneously. Researched for significant weight management, improved insulin sensitivity and enhanced metabolism. Supplied as 20mg per 3mL vial or as a pre-formulated peptide pen.

Research Areas

Weight Management Research
Insulin Sensitivity Research
Metabolic Health Research
Body Composition Research
Cardiovascular Research
Triple agonist (GLP-1, GIP & Glucagon)
Supports significant weight loss research
Improves insulin sensitivity
May enhance metabolism & energy expenditure
Available as vial or peptide pen
99%+ Purity, Research Grade
Laboratory tested — every batch

All products are for laboratory research purposes only. Not for human consumption. 99%+ purity. Sterile environment manufactured. Professional quality standards.

Customer Reviews

Loading reviews…